Pulse Biosciences (PLSE.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec18

Pulse Biosciences Inc. Receives FDA Approval to Initiate nPulse Catheter Ablation System Study

12:00

Dec9

Pulse Biosciences Inc. Collaborates with MD Anderson Cancer Center to Study Thyroid Cancer Treatment

12:01

Nov6

Oppenheimer Analyst Reiterates Buy Rating on Pulse Biosciences

14:32

Pulse Biosciences released FY2025 Q3 earnings on November 5 After-Market EST, actual revenue USD 86 K (forecast USD 500 K), actual EPS USD -0.2876 (forecast USD -0.31)

00:00

Pulse Biosciences released FY2025 9 Months Earnings on November 5 After-Market (EST), actual revenue USD 86K, actual EPS USD -0.8227

00:00

Oct29

Pulse Biosciences to Release FY2025 Q3 Earnings on November 5 After-Market EST, Forecast Revenue USD 500K, EPS USD -0.31

00:38

Schedules & Filings

Schedules

Filings

Nov5

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 86 K, Net Income -19.39 M, EPS -0.2876

Aug12

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -19.17 M, EPS -0.2849

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -16.8 M, EPS -0.2502

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change